Investigating how TGFß1 signaling affects the ability of neural stem cells to repair myelin damage.
Novel Modulators of TGFß1 signaling in regulation of remyelination by neural stem cells
This study is looking at how a certain pathway in the body affects the ability of brain cells to repair myelin, which is important for healthy nerve function, especially for people with Multiple Sclerosis, to find new ways to help them recover.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11041143 on NIH RePORTER |
What this research studies
This research focuses on understanding how a specific signaling pathway, TGFß1, influences the ability of neural stem cells to regenerate myelin, which is crucial for proper nerve function. The study aims to identify the molecular mechanisms that control remyelination, particularly in the context of diseases like Multiple Sclerosis. By analyzing gene expression in neural stem cells, researchers hope to uncover how these cells can be harnessed to promote repair in the brain after demyelination. This could lead to new therapeutic strategies for patients suffering from neurodegenerative conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with demyelinating conditions such as Multiple Sclerosis, particularly those experiencing symptoms related to myelin loss.
Not a fit: Patients with conditions unrelated to demyelination or those who are not experiencing neurological symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that promote myelin repair and improve outcomes for patients with demyelinating diseases.
How similar studies have performed: Previous research has shown promise in targeting similar pathways for promoting remyelination, indicating that this approach could be viable.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Samanta, Jayshree — University of Georgia
- Study coordinator: Samanta, Jayshree
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.